MB BS (HK), FRCR, FHKCR, FHKAM (Radiology)

Cancer immunotherapy has transformed oncological treatment, with 17 new FDA approvals in 2024 alone. From checkpoint inhibitors to CAR-T cell therapy and mRNA vaccines, these advances are delivering unprecedented survival benefits. Hong Kong stands at the forefront of immunotherapy research and clinical application in Asia.

Everything GCC patients need to know about medical tourism in Hong Kong — from visa-free entry for all 6 GCC nations to JCI-accredited hospitals, halal dining, Arabic-speaking coordinators, and cost savings of 30–50% compared to the US and UK.

A comprehensive evidence-based comparison of robotic prostatectomy, open surgery, and radiation therapy for prostate cancer — with outcomes data, recovery timelines, and cost comparisons for GCC patients considering treatment in Hong Kong.
Information presented complies with the Hong Kong Medical Council Code of Professional Conduct. Only factual, objectively verifiable information is displayed.